World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
79
Citations
24205
World Ranking
1676
National Ranking
60

Medicine

D-Index
80
Citations
24973
World Ranking
17050
National Ranking
571

Robert Booy publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Robert Booy sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 432 publications — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Robert Booy D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Robert Booy sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 79 D-Index — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Robert Booy is affiliated with the University of Sydney in Australia, focusing primarily on medicine with a substantial body of work in epidemiology and infectious diseases. Their research spans various subfields including modeling and simulation, public health, environmental and occupational health, as well as clinical psychology.

Their main topics of research encompass COVID-19 epidemiological studies, respiratory viral infections research, and influenza virus research. Other significant research areas include SARS-CoV-2 and COVID-19 research, travel-related health issues, vaccine coverage and hesitancy, and the intersection of COVID-19 and mental health.

Booy has contributed to a range of publication venues with multiple articles in the following journals:

  • SSRN Electronic Journal
  • Communicable Diseases Intelligence
  • Tropical Medicine and Infectious Disease
  • Human Vaccines & Immunotherapeutics
  • Expert Review of Vaccines

Recent notable papers include:

  • "School closure and management practices during coronavirus outbreaks including COVID-19: a rapid systematic review" (2020, The Lancet Child & Adolescent Health)
  • "Susceptibility to SARS-CoV-2 Infection Among Children and Adolescents Compared With Adults" (2020, JAMA Pediatrics)
  • "Epidemiology and clinical features of COVID-19 outbreaks in aged care facilities: A systematic review and meta-analysis" (2021, EClinicalMedicine)
  • "Susceptibility to SARS-CoV-2 infection amongst children and adolescents compared with adults: a systematic review and meta-analysis" (2020, bioRxiv (Cold Spring Harbor Laboratory))
  • "School Closure and Management Practices During Coronavirus Outbreaks Including COVID-19: A Rapid Narrative Systematic Review" (2020, SSRN Electronic Journal)

The scientist collaborates frequently with several researchers, including:

  • Gulam Khandaker
  • Harunor Rashid
  • Nicolas R. Smoll
  • Catherine King
  • Mohammad Alfelali

Best Publications

  • School closure and management practices during coronavirus outbreaks including COVID-19: a rapid systematic review.

    Russell M Viner;Simon J Russell;Helen Croker;Jessica Packer

  • Vaccination greatly reduces disease, disability, death and inequity worldwide.

    FE Andre;R Booy;HL Bock;J Clemens

  • Susceptibility to SARS-CoV-2 Infection Among Children and Adolescents Compared With Adults: A Systematic Review and Meta-analysis.

    Russell M. Viner;Oliver T. Mytton;Chris Bonell;G. J. Melendez-Torres

  • Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data.

    Stella G Muthuri;Sudhir Venkatesan;Puja R Myles;Jo Leonardi-Bee

  • Face mask use and control of respiratory virus transmission in households.

    C. Raina MacIntyre;Simon Cauchemez;Dominic E. Dwyer;Holly Seale

  • Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease

    Martin L Hibberd;Michiko Sumiya;John A Summerfield;Robert Booy

  • Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease.

    Chiea Chuen Khor;Chiea Chuen Khor;Sonia Davila;Sonia Davila;Willemijn B. Breunis;Yi Ching Lee

  • 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease

    Peter Wm Hermans;Martin L Hibberd;Robert Booy;Olufunmilayo Daramola

  • Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease

    Simon Nadel;Melanie J. Newport;Robert Booy;Michael Levin

  • Global Role and Burden of Influenza in Pediatric Respiratory Hospitalizations, 1982–2012: A Systematic Analysis

    Kathryn E. Lafond;Kathryn E. Lafond;Harish Nair;Harish Nair;Mohammad Hafiz Rasooly;Fátima Valente

  • Reduction in case fatality rate from meningococcal disease associated with improved healthcare delivery.

    R Booy;P Habibi;S Nadel;C de Munter

  • Severe and unrecognised: pertussis in UK infants.

    N S Crowcroft;R Booy;T Harrison;L Spicer

  • Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research

    P.A. Brogan;A. Bose;David Burgner;D. Shingadia

  • Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia

    James Buttery;Margie Danchin;Katherine Lee;John Carlin

  • Intradermal Influenza Vaccine Administered Using a New Microinjection System Produces Superior Immunogenicity in Elderly Adults: A Randomized Controlled Trial

    David Holland;Robert Booy;Ferdinandus De Looze;Peter Eizenberg

  • Body mass, weight control behaviours, weight perception and emotional well being in a multiethnic sample of early adolescents

    R M Viner;M M Haines;S J C Taylor;J Head

  • Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial

    Terry Nolan;Jodie McVernon;Maryanne Skeljo;Peter Richmond

  • Outcomes of invasive meningococcal serogroup B disease in children and adolescents (MOSAIC): a case-control study.

    Russell M Viner;Robert Booy;Helen Johnson;W John Edmunds

  • The role of healthcare delivery in the outcome of meningococcal disease in children: case-control study of fatal and non-fatal cases

    Nelly Ninis;Claire Phillips;Linda Bailey;Jon I Pollock

  • Diagnosis and treatment of bacterial meningitis

    H El Bashir;M Laundy;R Booy

Frequent Co-Authors

Dominic E. Dwyer
Dominic E. Dwyer University of Sydney
Peter Richmond
Peter Richmond University of Western Australia
Russell M. Viner
Russell M. Viner University College London
Michael Levin
Michael Levin Tufts University
Julie Leask
Julie Leask University of Sydney
Ziad A. Memish
Ziad A. Memish Emory University
Michael D. Nissen
Michael D. Nissen University of Queensland
Paul T. Heath
Paul T. Heath St George's, University of London
Russell C. Dale
Russell C. Dale University of Sydney
Peter McIntyre
Peter McIntyre University of Otago

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology can open doors to various healthcare careers, including specialized nursing roles that integrate immunological knowledge. For nurses interested in mental health, exploring the best pmhnp programs can provide excellent clinical placement opportunities, ensuring hands-on experience in psychiatric care.

Cost is often a major consideration, and prospective students may find value in the cheapest pmhnp certificate programs that offer quality education without a heavy financial burden. These programs enable nurses to specialize without compromising affordability.

Understanding remuneration is key for long-term career planning. The how much does a dnp make resource provides valuable insights into salary variations across different states for Doctor of Nursing Practice graduates, which can help inform where to practice and what career path to pursue.

For those currently working as Family Nurse Practitioners, transitioning to acute care roles is possible through bridge programs. Detailed guidance is available on the fnp to acute care np bridge program path, illustrating how specialized knowledge in immunology can enhance acute patient care abilities.

Best Scientists Citing Robert Booy

Trending Scientists

Recently Published Articles